Joy Y Feng

11PUBLICATIONS
49CO-AUTHORS
Molecular targetsBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMicro- and nanosystemsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

David R Martinez, Fernando R Moreira, Nicholas J Catanzaro

|Feb 01, 2023
Structural basis for substrate selection by the SARS-CoV-2 replicase.

Brandon F Malone, Jason K Perry, Paul Dominic B Olinares

|Dec 22, 2022
Interfering with nucleotide excision by the coronavirus 3'-to-5' exoribonuclease.

Rukesh Chinthapatla, Mohamad Sotoudegan, Pankaj Srivastava

|Jul 09, 2022
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2.

Joy Y Feng, Venice Du Pont, Darius Babusis

|Mar 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

Alexandra Schäfer, David R Martinez, John J Won

|Jun 12, 2021
Species-Specific Urothelial Toxicity With an Anti-HIV Noncatalytic Site Integrase Inhibitor (NCINI) Is Related to Unusual pH-Dependent Physicochemical Changes.

Ruth A Roberts, Richard A Campbell, Phumzile Sikakana

Pageof 2

Frequent Collaborators

3 joint publications

John P Bilello

3 joint publications

Timothy P Sheahan

3 joint publications

Jason K Perry

3 joint publications

Roy Bannister